Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contact Lenses, Hydrophilic | 18 | 2023 | 78 | 8.240 |
Why?
|
| Myopia | 13 | 2023 | 114 | 6.180 |
Why?
|
| Astigmatism | 6 | 2022 | 35 | 3.690 |
Why?
|
| Contact Lenses | 5 | 2022 | 71 | 2.270 |
Why?
|
| Orthokeratologic Procedures | 5 | 2023 | 9 | 1.850 |
Why?
|
| Humans | 35 | 2024 | 5476 | 1.790 |
Why?
|
| Atropine | 2 | 2023 | 9 | 1.570 |
Why?
|
| Adult | 17 | 2023 | 1683 | 1.470 |
Why?
|
| Visual Acuity | 6 | 2022 | 179 | 1.260 |
Why?
|
| Tears | 5 | 2022 | 21 | 1.180 |
Why?
|
| Lens, Crystalline | 4 | 2024 | 34 | 1.070 |
Why?
|
| Refraction, Ocular | 8 | 2023 | 127 | 1.070 |
Why?
|
| Young Adult | 10 | 2022 | 850 | 1.060 |
Why?
|
| Keratitis | 2 | 2023 | 3 | 0.990 |
Why?
|
| Eyeglasses | 2 | 2022 | 30 | 0.950 |
Why?
|
| Eye Diseases | 2 | 2022 | 17 | 0.930 |
Why?
|
| Child | 8 | 2023 | 657 | 0.880 |
Why?
|
| Quality of Life | 2 | 2022 | 117 | 0.870 |
Why?
|
| Lenses, Intraocular | 2 | 2021 | 9 | 0.870 |
Why?
|
| Corneal Diseases | 1 | 2023 | 10 | 0.800 |
Why?
|
| Corneal Ulcer | 2 | 2021 | 4 | 0.780 |
Why?
|
| Patient Satisfaction | 1 | 2022 | 28 | 0.770 |
Why?
|
| Glucose | 1 | 2022 | 13 | 0.770 |
Why?
|
| Patient Education as Topic | 1 | 2022 | 9 | 0.760 |
Why?
|
| Insulin | 1 | 2022 | 31 | 0.760 |
Why?
|
| Parents | 1 | 2022 | 59 | 0.740 |
Why?
|
| Surveys and Questionnaires | 6 | 2022 | 277 | 0.730 |
Why?
|
| Hyperemia | 1 | 2021 | 4 | 0.720 |
Why?
|
| Accommodation, Ocular | 2 | 2024 | 36 | 0.690 |
Why?
|
| Male | 11 | 2023 | 2765 | 0.670 |
Why?
|
| Female | 11 | 2023 | 2811 | 0.670 |
Why?
|
| Computers | 1 | 2020 | 16 | 0.660 |
Why?
|
| Disease Management | 1 | 2020 | 6 | 0.660 |
Why?
|
| Dry Eye Syndromes | 1 | 2020 | 12 | 0.650 |
Why?
|
| Diabetic Retinopathy | 1 | 2020 | 11 | 0.650 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 33 | 0.630 |
Why?
|
| Adolescent | 6 | 2022 | 806 | 0.630 |
Why?
|
| Eye Infections, Bacterial | 1 | 2018 | 2 | 0.600 |
Why?
|
| Cornea | 4 | 2021 | 140 | 0.600 |
Why?
|
| Cytokines | 1 | 2018 | 37 | 0.590 |
Why?
|
| Microbiota | 1 | 2018 | 18 | 0.580 |
Why?
|
| Risk Factors | 7 | 2022 | 184 | 0.540 |
Why?
|
| Conjunctiva | 3 | 2022 | 13 | 0.520 |
Why?
|
| Case-Control Studies | 3 | 2022 | 96 | 0.500 |
Why?
|
| Aging | 2 | 2024 | 127 | 0.480 |
Why?
|
| Refractive Errors | 1 | 2016 | 58 | 0.460 |
Why?
|
| Pilot Projects | 4 | 2022 | 119 | 0.410 |
Why?
|
| Cross-Over Studies | 3 | 2022 | 31 | 0.400 |
Why?
|
| Ophthalmic Solutions | 2 | 2023 | 7 | 0.400 |
Why?
|
| Disease Progression | 3 | 2022 | 74 | 0.390 |
Why?
|
| Prospective Studies | 2 | 2023 | 132 | 0.380 |
Why?
|
| Retrospective Studies | 3 | 2023 | 382 | 0.370 |
Why?
|
| Prediabetic State | 2 | 2020 | 9 | 0.340 |
Why?
|
| Contrast Sensitivity | 2 | 2021 | 64 | 0.330 |
Why?
|
| Retina | 2 | 2022 | 130 | 0.320 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 37 | 0.320 |
Why?
|
| Disposable Equipment | 2 | 2022 | 2 | 0.250 |
Why?
|
| Incidence | 2 | 2023 | 33 | 0.250 |
Why?
|
| Proteome | 2 | 2022 | 9 | 0.240 |
Why?
|
| Proteomics | 2 | 2022 | 23 | 0.240 |
Why?
|
| Blood Glucose | 2 | 2022 | 31 | 0.230 |
Why?
|
| Presbyopia | 1 | 2024 | 5 | 0.220 |
Why?
|
| Vision Tests | 2 | 2021 | 50 | 0.210 |
Why?
|
| Drug Compounding | 1 | 2023 | 4 | 0.200 |
Why?
|
| Students, Health Occupations | 1 | 2022 | 1 | 0.200 |
Why?
|
| United States | 2 | 2022 | 521 | 0.200 |
Why?
|
| United States Food and Drug Administration | 1 | 2022 | 6 | 0.200 |
Why?
|
| Medicine | 1 | 2022 | 4 | 0.200 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2022 | 2 | 0.200 |
Why?
|
| Glucose Tolerance Test | 1 | 2022 | 3 | 0.200 |
Why?
|
| Pharmacy | 1 | 2022 | 16 | 0.190 |
Why?
|
| Contact Lenses, Extended-Wear | 1 | 2021 | 1 | 0.180 |
Why?
|
| Software | 1 | 2021 | 59 | 0.180 |
Why?
|
| Risk-Taking | 1 | 2020 | 16 | 0.170 |
Why?
|
| Corneal Topography | 1 | 2021 | 37 | 0.170 |
Why?
|
| Ophthalmic Nerve | 1 | 2020 | 2 | 0.170 |
Why?
|
| Axial Length, Eye | 2 | 2023 | 25 | 0.170 |
Why?
|
| Double-Blind Method | 1 | 2020 | 34 | 0.170 |
Why?
|
| Endothelial Cells | 1 | 2020 | 48 | 0.160 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2019 | 1 | 0.160 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2019 | 2 | 0.160 |
Why?
|
| Interleukin-8 | 1 | 2019 | 4 | 0.160 |
Why?
|
| Dendritic Cells | 1 | 2019 | 10 | 0.160 |
Why?
|
| Reading | 1 | 2020 | 77 | 0.150 |
Why?
|
| Epithelium, Corneal | 1 | 2019 | 13 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 20 | 0.150 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2018 | 1 | 0.150 |
Why?
|
| DNA, Ribosomal | 1 | 2018 | 5 | 0.150 |
Why?
|
| Interleukin-6 | 1 | 2018 | 9 | 0.150 |
Why?
|
| Environment | 1 | 2018 | 10 | 0.150 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 20 | 0.150 |
Why?
|
| Middle Aged | 3 | 2020 | 1098 | 0.150 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 20 | 0.150 |
Why?
|
| Genotype | 1 | 2018 | 58 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 52 | 0.150 |
Why?
|
| Eye Proteins | 1 | 2018 | 36 | 0.140 |
Why?
|
| Microscopy, Acoustic | 1 | 2016 | 5 | 0.120 |
Why?
|
| Corneal Pachymetry | 1 | 2016 | 7 | 0.120 |
Why?
|
| Interferometry | 1 | 2016 | 6 | 0.120 |
Why?
|
| Anterior Eye Segment | 1 | 2016 | 12 | 0.120 |
Why?
|
| Tomography, Optical Coherence | 1 | 2016 | 217 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 250 | 0.100 |
Why?
|
| Cell Count | 2 | 2020 | 33 | 0.080 |
Why?
|
| Microscopy, Confocal | 2 | 2020 | 49 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 284 | 0.070 |
Why?
|
| Aged | 2 | 2020 | 859 | 0.060 |
Why?
|
| Attitude | 1 | 2022 | 14 | 0.050 |
Why?
|
| Health Occupations | 1 | 2022 | 1 | 0.050 |
Why?
|
| Problem-Based Learning | 1 | 2022 | 6 | 0.050 |
Why?
|
| Self Report | 1 | 2022 | 72 | 0.050 |
Why?
|
| Electroretinography | 1 | 2020 | 57 | 0.040 |
Why?
|
| Nerve Fibers | 1 | 2020 | 56 | 0.040 |
Why?
|
| Psychometrics | 1 | 2020 | 101 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2019 | 6 | 0.040 |
Why?
|
| Methacrylates | 1 | 2019 | 4 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 21 | 0.040 |
Why?
|
| Silicones | 1 | 2019 | 11 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 10 | 0.040 |
Why?
|
| Slit Lamp Microscopy | 1 | 2019 | 2 | 0.040 |
Why?
|
| Hydrogels | 1 | 2019 | 15 | 0.040 |
Why?
|
| Off-Label Use | 1 | 2019 | 1 | 0.040 |
Why?
|
| Informed Consent | 1 | 2019 | 2 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 5 | 0.040 |
Why?
|
| Internationality | 1 | 2019 | 6 | 0.040 |
Why?
|
| Age Factors | 1 | 2019 | 75 | 0.040 |
Why?
|
| Protein Binding | 1 | 2019 | 118 | 0.040 |
Why?
|
| Habits | 1 | 2017 | 2 | 0.040 |
Why?
|
| Consumer Behavior | 1 | 2017 | 2 | 0.040 |
Why?
|